DrugPatentWatch Database Preview
ZETONNA Drug Profile
When do Zetonna patents expire, and when can generic versions of Zetonna launch?
Zetonna is a drug marketed by Covis Pharma Bv and is included in one NDA. There is one patent protecting this drug.
This drug has thirteen patent family members in eleven countries.
The generic ingredient in ZETONNA is ciclesonide. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ciclesonide profile page.
Summary for ZETONNA
| International Patents: | 13 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 44 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,683 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ZETONNA |
| DailyMed Link: | ZETONNA at DailyMed |
Recent Clinical Trials for ZETONNA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sunovion | Phase 4 |
Synonyms for ZETONNA
| (11?,16?)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4-diene-3,20-dione |
| (11?,16?)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)pregna-1,4-diene-3,20-dione |
| (11|A,16|A)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4-diene-3,20-dione |
| (R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate |
| 126544-47-6 |
| 141845-82-1 |
| 2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)- |
| 2-oxoethyl isobutyrate |
| 2H-Naphth (2',1':4,5) indeno (1,2-d) (1,3) dioxole, pregna-1,4-diene-3,20-dione deriv. |
| 544C476 |
| AC-1330 |
| AC1MIWNR |
| AKOS015994702 |
| Alvesco |
| Alvesco (TN) |
| Alvesco HFA |
| Alvesco, Ciclesonide |
| AN-15021 |
| B-9207-015 |
| BC220461 |
| BTR-15 |
| BTR-15K |
| BY-9010 |
| BYK-20426 |
| C-23151 |
| C32H44O7 |
| CAS-141845-82-1 |
| CC-25775 |
| CHEBI:31397 |
| CHEMBL2040682 |
| Ciclesonide |
| Ciclesonide (JAN/USAN/INN) |
| Ciclesonide [INN] |
| Ciclesonide [USAN:INN] |
| Ciclesonide, >=98% (HPLC) |
| Ciclesonide, European Pharmacopoeia (EP) Reference Standard |
| CS-2867 |
| D01703 |
| DB01410 |
| DSSTox_CID_26659 |
| DSSTox_GSID_46659 |
| DSSTox_RID_81802 |
| DTXSID9046659 |
| el-87-6 |
| GTPL7469 |
| HMS3714N07 |
| HY-B0625 |
| KS-1165 |
| LS-186047 |
| LUKZNWIVRBCLON-GXOBDPJESA-N |
| MolPort-005-940-705 |
| NCGC00167484-01 |
| NCGC00167972-01 |
| O945 |
| Omnair |
| Omnaris |
| Omnaris (TN) |
| Omnaris HFA |
| Osonase |
| Osonide |
| Pregna-1,4-diene-3,20-dione, 16,17-(((R)-cyclohexylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-, (11beta,16alpha)- |
| Pregna-1,4-diene-3,20-dione, 16,17-((cyclohexylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-, (11beta,16alpha(R))- |
| RPR 251526 |
| RPR-251526 |
| RPR251526 |
| s4646 |
| S59502J185 |
| SCHEMBL3688 |
| SR-01000942227 |
| SR-01000942227-1 |
| TBN-15 |
| Tox21_112486 |
| UNII-S59502J185 |
| ZINC3915154 |
US Patents and Regulatory Information for ZETONNA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Covis Pharma Bv | ZETONNA | ciclesonide | AEROSOL, METERED;NASAL | 202129-001 | Jan 20, 2012 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZETONNA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Covis Pharma Bv | ZETONNA | ciclesonide | AEROSOL, METERED;NASAL | 202129-001 | Jan 20, 2012 | Start Trial | Start Trial |
| Covis Pharma Bv | ZETONNA | ciclesonide | AEROSOL, METERED;NASAL | 202129-001 | Jan 20, 2012 | Start Trial | Start Trial |
| Covis Pharma Bv | ZETONNA | ciclesonide | AEROSOL, METERED;NASAL | 202129-001 | Jan 20, 2012 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZETONNA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Croatia | P20140257 | Start Trial |
| Spain | 2452691 | Start Trial |
| Denmark | 1670482 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
